BPA-free Tritan gives product line superior clarity, chemical and lipid resistance
Kingsport, Tenn., USA — Nov. 20, 2013 — In response to an industry need for a high-performance product that is free of bisphenol A (BPA), DMC Medical Ltd. has developed a range of NuGen™ syringes made with Eastman Tritan™ copolyester. Eastman Chemical Company is showcasing the new syringes at Stand 8aP04 in Hall 8a at the COMPAMED trade fair in Düsseldorf, Germany. Tritan is a BPA-free, new-generation copolyester that provides increased chemical and lipid resistance, and glasslike clarity.
With the NuGen™ line, DMC Medical Ltd. is bringing premium, quality syringes to the market. The product line consists of color-coded luer lock syringes in the following sizes: 1 ml, 3 ml, 6 ml, 10 ml, 20 ml and 30 ml. The accompanying plunger will be available in seven colors in all sizes.
Eastman Tritan™ copolyester provides outstanding chemical and lipid resistance to the devices, which frequently come into contact with these substances, including aggressive disinfectants, specific drugs and carriers of therapeutic drugs. The material also provides superior clarity, allowing health care practitioners to easily see the syringe’s contents.
Suitable for ethylene oxide and radiation (gamma and electron beam) sterilization, Eastman Tritan™ copolyester also provides benefits for the syringes, as devices made with the material retain their color and functionality post-sterilization.
“When developing the NuGen™ line, we looked for a material that provided the range of benefits necessary of such devices and demanded by the industry. We found the answer in Eastman Tritan™ copolyester,” said Bryan Wixted, CEO, DMC Medical Ltd. “The advantages Tritan provides — in particular, being free of BPA — put DMC Medical at the leading edge of premium syringe development and supply.”
Eastman Tritan™ copolyester has been used for a wide spectrum of medical devices since 2009. As part of its offering, Eastman lends its industry understanding to medical original equipment manufacturers throughout every step of the development process.
“As a committed medical polymer collaborator, Eastman leverages its industry insight and extensive design, engineering and manufacturing expertise to help customers develop products, bring them to market quickly and follow through with strong technical support,” said Theo Wubbels, medical market development manager, EMEA, Eastman Chemical Advanced Materials B.V.
For the NuGen™ syringes, Eastman provided technical expertise to help DMC Medical through the fabrication process and to seamlessly bring the product to market.
“From the outset of this collaboration, the communication, follow up and technical support from Eastman has been excellent,” Wixted said. “The company’s attention to detail and understanding of DMC’s needs during the trial stages were greatly appreciated.”
The NuGen™ syringe range will be available to a global market, primarily targeting medical device and pharmaceutical companies that will include the syringes in custom kits or pre-fill them with specific drugs.
For more information about Eastman Tritan™ copolyester, visit www.eastman.com/medical.
For more information about the NuGen™ range of syringes, contact firstname.lastname@example.org.
About DMC Medical Ltd.
Founded in 1998, DMC Medical Ltd. specializes in the manufacture and distribution of cardiovascular accessories for open heart surgery. DMC also manufactures a comprehensive range of custom color-coded syringes and connectors in sterile and non-sterile formats for supply to a global market. DMC supplies to distributors, custom-kit packers and hospitals direct. The company’s logistics, regulatory and sales functions are based in Europe and the United States. Innovation, research and development are key components to DMC’s philosophy, and the company welcomes the opportunity to work with customers to answering their specific needs.
For more information, visit www.dmcmedical.net.